| Mitch D Mcswain, RPH | |
|
1910 Main Ave Sw, Cullman, AL 35055-5219 | |
| (256) 734-1662 | |
| (256) 737-0682 |
| Full Name | Mitch D Mcswain |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1910 Main Ave Sw, Cullman, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598859191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 110649 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mitch D Mcswain, RPH 1910 Main Ave Sw, Cullman, AL 35055-5219 Ph: (256) 734-1662 | Mitch D Mcswain, RPH 1910 Main Ave Sw, Cullman, AL 35055-5219 Ph: (256) 734-1662 |
News Archive
In a follow-up to her earlier studies of learning in infancy, developmental psychologist Lisa Scott and colleagues at the University of Massachusetts Amherst are reporting that talking to babies in their first year, in particular naming things in their world, can help them make connections between what they see and hear, and these learning benefits can be seen as much as five years later.
The American Society for Radiation Oncology has issued a new white paper, "A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy," that recommends specific guidance to follow in the delivery of high-dose-rate (HDR) brachytherapy to improve quality and patient safety, according to the manuscript published in the March-April 2014 print issue of Practical Radiation Oncology, the official clinical practice journal of ASTRO.
Novartis today presented results from a pivotal Phase III clinical trial exploratory subgroup analysis showing a 7.8-month improvement in median progression-free survival when using Farydak in combination with bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who had received two or more prior regimens, including bortezomib and an immunomodulatory agent.
Engineers have created a tiny device that can rapidly detect harmful bacteria in blood, allowing health care professionals to pinpoint the cause of potentially deadly infections and fight them with drugs.
› Verified 7 days ago
Mrs. Roxanne E Mauldin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1910 Main Ave Sw, Cullman, AL 35055 Phone: 256-734-1662 Fax: 256-737-0682 | |
Dr. Stephanie Brooke Matthews, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2104 Al Highway 157, Cullman, AL 35058 Phone: 256-734-3416 | |
Dr. Anna Usaha Intraboona, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 626 Olive St Sw, Cullman, AL 35055 Phone: 256-739-3390 | |
Ms. Rita Kay Freeman, RPHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1701 Main Ave Sw, Suite C, Cullman, AL 35055 Phone: 256-737-3773 Fax: 256-737-3775 | |
Dr. Hunter Dale Cunningham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1104 Cullman Shopping Ctr Nw, Cullman, AL 35055 Phone: 256-736-7005 | |
Kelly Gerrard, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 2nd Ave Sw, Cullman, AL 35055 Phone: 256-734-7188 | |
Mrs. Cynthia Hayslette Doggett, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1731 2nd Ave Sw, Cullman, AL 35055 Phone: 205-734-8935 Fax: 205-734-3430 |